Concurrently, it has been observed that CAFs-Exos upregulate PD-L1 on the surface of lung cancer cells, thereby inhibiting the peripheral blood mononuclear cells' (PBMC) ability to induce the killing of lung cancer cells [125]. Here, CD274 is linked to lung carcinoma.